Biopsy technology for improved precision and safety

I noticed patients returning for a re-biopsy due to results being inconclusive.

They seemed exhausted and anxious, as the delays in diagnosis and the high risk of complications, such as collapsed lungs, weighed heavily.

I realized that many of these insufficiencies and complications could be solved with better equipment and training”

Inspired by Exprience

About us

Lung cancer is the leading cause of cancer-related deaths, with less than one-third of patients expected to survive more than five years post-diagnosis

We develop advanced user-centered biopsy technology, which aims to ensure early and a more accurate cancer diagnosis, the key for better treatment and patient care

Reach out or meet us at one of our locations in Denmark

At Republikken Create

Vesterbrogade 35A, st. tv,

1620 Copenhagen, Denmark

Copenhagen

Aarhus

At Incuba Katrinebjerg

Åbogade 15,

8200 Aarhus, Denmark

Meet MultiBiopsy

Victor Pedersen

Caroline Jensen

Caroline Bering

Media &
Communication

Claus Baumann

R&D Consultant

William Ludvigsen

Kristian Horsager

Co-founder,
CEO, Doctor

Co-founder,
COO, Engineer

Co-founder,
Clinical Expert, Doctor

Anton Esbjerg

Co-founder,
CTO, Engineer

Claus Tvedesøe

R&D, Engineer

R&D, Engineer

MultiBiopsy

info@multibiopsy.com

LinkedIn.com